STRATEC Biomedical AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
STRATEC Biomedical AG
Dissemination of a Voting Rights Announcement, transmitted by
DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
BNP Paribas Investment Partners S.A., Paris, France has notified us
pursuant to sec. 21 para. 1 WpHG on 15 January 2015, that on 15 January
2015 the share of voting rights in STRATEC Biomedical AG, Birkenfeld,
Germany, ISIN: DE0007289001 went above the threshold of 3% and that the
percentage of voting rights on that day amounted to 3.02% (356,478 voting
Of these voting rights 3.02% (356,478 voting rights) are attributable to
BNP Paribas Investment Partners S.A., pursuant to sec. 22 para. 1 sent. 1
no. 1 WpHG.
Also, of these voting rights 2.95% (347,651 voting rights) are attributable
to BNP Paribas Investment Partners S.A., pursuant to sec. 22 para. 1 sent.
1 no. 6 in connection with sent. 2 WpHG.
19.01.2015 The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
Company: STRATEC Biomedical AG
End of Announcement DGAP News-Service